Comparison Chart Fulcrum Therapeutics, Inc.

Stocks

FULC

US3596161097

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:00 2026-10-22 EDT			5-day change	1st Jan Change
3.680 ^USD	-0.54%		+0.27%	-67.46%

09-20	Fulcrum Therapeutics, Inc.(NasdaqGM:FULC) dropped from S&P Pharmaceuticals Select Industry Index	CI
08-17	Slate Medicines, Inc. entered into an agreement and plan of merger to acquire Fulcrum Therapeutics, Inc. for $350 million in a reverse merger transaction.	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	FULCRUM THERAPEUTICS, INC.	Other Biotechnology & Medical Research	-0.54%	+0.27%	-67.46%	-59.29%	-85.14%	281M